Search research articles
Contact Us
Filters
Showing results (211-220 of 241) with videos related to
Page
of 25
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
August 28, 2013
Molecular screening for a personalized treatment approach in advanced adrenocortical cancer
Maria Cristina De Martino, Abir Al Ghuzlan, Sebastien Aubert, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 26, 2013
One-year progression-free survival of therapy-naive patients with malignant pheochromocytoma and paraganglioma
Ségolène Hescot, Sophie Leboulleux, Laurence Amar, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 21, 2018
Clinicopathological description of 43 oncocytic adrenocortical tumors: importance of Ki-67 in histoprognostic evaluation
Karine Renaudin, Sarra Smati, Matthieu Wargny, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 5, 2021
Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN network
Julien Hadoux, Christina Kanaan, Alice Durand, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 4, 2019
Everolimus after hepatic arterial embolisation therapy of metastases from gastrointestinal neuroendocrine tumours: The FFCD 1104-EVACEL-GTE phase II study
Thomas Walter, Come Lepage, Romain Coriat, et al.
Communications Medicine
|
July 6, 2026
OncoMimic peptide-based immunotherapy EO2401 induces shared T cell clusters in patients with adrenal cancer
Christoph Schultheiß, Brenda Besemer, Edith Willscher, et al.
Thyroid : Official Journal of the American Thyroid Association
|
October 19, 2023
Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF Network
Arnaud Jannin, Fabiola Giudici, Christelle de la Fouchardière, et al.
Annals of Surgery
|
December 27, 2018
Metastatic Potential and Survival of Duodenal and Pancreatic Tumors in Multiple Endocrine Neoplasia Type 1: A GTE and AFCE Cohort Study (Groupe d'étude des Tumeurs Endocrines and Association Francophone de Chirurgie Endocrinienne)
Sandrine Vinault, Anne-Sophie Mariet, Maëlle Le Bras, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 30, 2021
Recurrence-Free Survival Analysis in Locally Advanced Pheochromocytoma: First Appraisal
Sophie Moog, Frédéric Castinetti, Christine DoCao, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 7, 2015
Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection
Felix Beuschlein, Jens Weigel, Wolfgang Saeger, et al.
Page
of 25
Search research articles
Search
Showing results (211-220 of 241) with videos related to
Sort By:
Page
of 25
The Journal of Clinical Endocrinology and Metabolism
|
August 28, 2013
Molecular screening for a personalized treatment approach in advanced adrenocortical cancer
Maria Cristina De Martino, Abir Al Ghuzlan, Sebastien Aubert, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 26, 2013
One-year progression-free survival of therapy-naive patients with malignant pheochromocytoma and paraganglioma
Ségolène Hescot, Sophie Leboulleux, Laurence Amar, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 21, 2018
Clinicopathological description of 43 oncocytic adrenocortical tumors: importance of Ki-67 in histoprognostic evaluation
Karine Renaudin, Sarra Smati, Matthieu Wargny, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 5, 2021
Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN network
Julien Hadoux, Christina Kanaan, Alice Durand, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 4, 2019
Everolimus after hepatic arterial embolisation therapy of metastases from gastrointestinal neuroendocrine tumours: The FFCD 1104-EVACEL-GTE phase II study
Thomas Walter, Come Lepage, Romain Coriat, et al.
Communications Medicine
|
July 6, 2026
OncoMimic peptide-based immunotherapy EO2401 induces shared T cell clusters in patients with adrenal cancer
Christoph Schultheiß, Brenda Besemer, Edith Willscher, et al.
Thyroid : Official Journal of the American Thyroid Association
|
October 19, 2023
Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF Network
Arnaud Jannin, Fabiola Giudici, Christelle de la Fouchardière, et al.
Annals of Surgery
|
December 27, 2018
Metastatic Potential and Survival of Duodenal and Pancreatic Tumors in Multiple Endocrine Neoplasia Type 1: A GTE and AFCE Cohort Study (Groupe d'étude des Tumeurs Endocrines and Association Francophone de Chirurgie Endocrinienne)
Sandrine Vinault, Anne-Sophie Mariet, Maëlle Le Bras, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 30, 2021
Recurrence-Free Survival Analysis in Locally Advanced Pheochromocytoma: First Appraisal
Sophie Moog, Frédéric Castinetti, Christine DoCao, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 7, 2015
Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection
Felix Beuschlein, Jens Weigel, Wolfgang Saeger, et al.
Page
of 25